1. Home
  2. EVC vs MDWD Comparison

EVC vs MDWD Comparison

Compare EVC & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVC
  • MDWD
  • Stock Information
  • Founded
  • EVC 1996
  • MDWD 2000
  • Country
  • EVC United States
  • MDWD Israel
  • Employees
  • EVC N/A
  • MDWD N/A
  • Industry
  • EVC Broadcasting
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • EVC Industrials
  • MDWD Health Care
  • Exchange
  • EVC Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • EVC 166.9M
  • MDWD 179.1M
  • IPO Year
  • EVC 2000
  • MDWD 2014
  • Fundamental
  • Price
  • EVC $1.95
  • MDWD $17.61
  • Analyst Decision
  • EVC Hold
  • MDWD Strong Buy
  • Analyst Count
  • EVC 1
  • MDWD 1
  • Target Price
  • EVC $1.75
  • MDWD $28.00
  • AVG Volume (30 Days)
  • EVC 262.6K
  • MDWD 60.7K
  • Earning Date
  • EVC 10-31-2024
  • MDWD 08-14-2024
  • Dividend Yield
  • EVC 10.18%
  • MDWD N/A
  • EPS Growth
  • EVC N/A
  • MDWD N/A
  • EPS
  • EVC N/A
  • MDWD N/A
  • Revenue
  • EVC $1,126,331,000.00
  • MDWD $20,141,000.00
  • Revenue This Year
  • EVC N/A
  • MDWD $30.16
  • Revenue Next Year
  • EVC N/A
  • MDWD $18.44
  • P/E Ratio
  • EVC N/A
  • MDWD N/A
  • Revenue Growth
  • EVC 65.95
  • MDWD N/A
  • 52 Week Low
  • EVC $1.33
  • MDWD $7.45
  • 52 Week High
  • EVC $4.41
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • EVC 48.41
  • MDWD 48.27
  • Support Level
  • EVC $1.88
  • MDWD $16.25
  • Resistance Level
  • EVC $2.08
  • MDWD $17.48
  • Average True Range (ATR)
  • EVC 0.09
  • MDWD 1.04
  • MACD
  • EVC -0.00
  • MDWD -0.12
  • Stochastic Oscillator
  • EVC 27.69
  • MDWD 31.63

About EVC Entravision Communications Corporation

Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: